786
Participants
Start Date
May 26, 2022
Primary Completion Date
December 31, 2024
Study Completion Date
June 1, 2025
Xpert® MTB/XDR
The Xpert MTB/XDR Assay, performed on the GeneXpert Instrument Systems, is a nested real-time polymerase chain reaction(PCR) in vitro diagnostic test for the detection of extensively drug resistant (XDR) Mycobacterium tuberculosis (MTB) complex DNA in unprocessed sputum samples or concentrated sediments prepared from sputum. In specimens where MTB is detected, the Xpert MTB/XDR Assay can also detect isoniazid (INH) resistance associated mutations in the katG and fabG1 genes, oxyRahpC intergenic region and inhA promoter; ethionamide (ETH) resistance associated with inhA promoter mutations only; fluoroquinolone (FLQ) resistance associated mutations in the gyrA and gyrB quinolone resistance determining regions (QRDR); and second line injectable drug (SLID) associated mutations in the rrs gene and the eis promoter region.
CAPRISA Springfield Research Clinic, Durban
Clinical HIV Research Unit (CHRU), WITS Health Consortium, Bethelsdorp
Ethiopian Public Health Institute (EPHI), Gulele
Institute of Human Virology Nigeria, Yaba
KNCV Tuberculosis Foundation
OTHER
Amsterdam Institute for Global Health and Development
OTHER
Ospedale San Raffaele
OTHER
Foundation for Innovative New Diagnostics, Switzerland
OTHER
National Institute for Medical Research, Tanzania
OTHER_GOV
University of St Andrews
OTHER
Global Alliance for TB Drug Development
OTHER
Wits Health Consortium (Pty) Ltd
OTHER
Institute of Human Virology, Nigeria
OTHER
Ethiopian Public Health Institute
OTHER_GOV
Centre for the AIDS Programme of Research in South Africa
NETWORK